The Attack on Titan movie is now out in Japan, and details are spilling out from audiences about what to expect and what changes have been made to the anime's endgame. A feature-length ...

Titan offers a distinctive strategy for investment management, but doesn't have some of the perks offered by other firms. Many, or all, of the products featured on this page are from our ...

Tom Tedeschi, chief audiology director for Amplifon Hearing Health Care. Utah-based Tedeschi, who is also a Vietnam-era Army veteran, shared with Fox News Digital how prevalent hearing loss and ...

Our Titan Warfare codes gets you an in-game boost to power up your avatar in this PvP game which pits Marleyans and Eldians against each other. Grab some free keys or cash and get started leveling up ...

Titan Q4 Results Today: Titan Company poised for strong Q4 performance with high double-digit revenue growth. Jewelry segment expected to lead with significant EBITDA and PAT growth. Various factors ...

President-elect Donald Trump has started to make some of the pivotal picks for his second administration after swiftly ...

He further advised not to short Titan at lower levels. Anil Singhvi recommends buying Titan Futures in today’s weakness for the next 6 months. He said the stock's support level is placed at Rs 3,130 ...

Though it's very early days, Mark Rylance (Bridge of Spies, Dunkirk) is reportedly at the top of Warner Bros.' wishlist to ...

In an unsurprising move, they shared that Jeannot will have a hearing for the check. The Department announced the update via their X account. Los Angeles’ Tanner Jeannot will have a hearing ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Your music listening habits could be putting your hearing at risk. A recent study ...

Voting is underway in Kerala's Wayanad Lok Sabha constituency for the by-election. Congress leader Priyanka Gandhi Vadra is making her electoral debut against 15 other candidates. The bypoll was ...

Regeneron’s gene therapy for otoferlin-related hearing loss – a genetic cause of deafness – has restored hearing to normal levels in one profoundly deaf child within just 24 weeks.